These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38945415)

  • 1. Troponin levels in transient ischemic attack and ischemic stroke: does "transient" in your brain mean "better" for your heart?
    Prandin G; Caruso P; Furlanis G; Rossi L; Cegalin M; Scali I; Mancinelli L; Palacino F; Vincis E; Naccarato M; Manganotti P
    J Stroke Cerebrovasc Dis; 2024 Sep; 33(9):107844. PubMed ID: 38945415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) Levels are Increased in Patients With Transient Ischemic Attack Accompanied by Nonfocal Symptoms.
    Plas GJ; Jurg SD; Brusse-Keizer M; Dippel DW; Koudstaal PJ; den Hertog HM
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26672079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NT-pro-BNP: A novel predictor of stroke risk after transient ischemic attack.
    Rodríguez-Castro E; Hervella P; López-Dequidt I; Arias-Rivas S; Santamaría-Cadavid M; López-Loureiro I; da Silva-Candal A; Pérez-Mato M; Sobrino T; Campos F; Castillo J; Rodríguez-Yáñez M; Iglesias-Rey R
    Int J Cardiol; 2020 Jan; 298():93-97. PubMed ID: 31272739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide and the risk of stroke and transient ischaemic attack: the Rotterdam Study.
    Portegies ML; Kavousi M; Leening MJ; Bos MJ; van den Meiracker AH; Hofman A; Franco OH; Koudstaal PJ; Ikram MA
    Eur J Neurol; 2015 Apr; 22(4):695-701. PubMed ID: 25573143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troponin I and NT-proBNP (N-terminal pro-brain natriuretic peptide) do not predict 6-month mortality in frail older patients undergoing orthopedic surgery.
    Chong CP; van Gaal WJ; Ryan JE; Burrell LM; Savige J; Lim WK
    J Am Med Dir Assoc; 2010 Jul; 11(6):415-20. PubMed ID: 20627182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation.
    Purroy F; Suárez-Luis I; Mauri-Capdevila G; Cambray S; Farré J; Sanahuja J; Piñol-Ripoll G; Quílez A; González-Mingot C; Begué R; Gil MI; Fernández E; Benabdelhak I
    Eur J Neurol; 2014 Apr; 21(4):679-83. PubMed ID: 23800180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moderate Levels of N-Terminal Pro-B-Type Natriuretic Peptide is Associated with Increased Risks of Total and Ischemic Strokes among Japanese: The Circulatory Risk in Communities Study.
    Ebihara K; Yamagishi K; Umesawa M; Muraki I; Cui R; Imano H; Kubota Y; Hayama-Terada M; Shimizu Y; Ohira T; Sankai T; Okada T; Kitamura A; Kiyama M; Iso H;
    J Atheroscler Thromb; 2020 Aug; 27(8):751-760. PubMed ID: 31932552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood biomarkers for the diagnosis of acute cerebrovascular diseases: a prospective cohort study.
    Whiteley W; Wardlaw J; Dennis M; Lowe G; Rumley A; Sattar N; Welsh P; Green A; Andrews M; Graham C; Sandercock P
    Cerebrovasc Dis; 2011; 32(2):141-7. PubMed ID: 21778711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Troponin elevation predicts atrial fibrillation in patients with stroke or transient ischemic attack.
    Beaulieu-Boire I; Leblanc N; Berger L; Boulanger JM
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):978-83. PubMed ID: 22341670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarkers and mortality after transient ischemic attack and minor ischemic stroke: population-based study.
    Greisenegger S; Segal HC; Burgess AI; Poole DL; Mehta Z; Rothwell PM
    Stroke; 2015 Mar; 46(3):659-66. PubMed ID: 25649803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Hypertension; 2005 Jan; 45(1):69-74. PubMed ID: 15569851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-terminal pro-B-type natriuretic peptide and microsize myocardial infarction risk in the reasons for geographic and racial differences in stroke study.
    Sterling MR; Durant RW; Bryan J; Levitan EB; Brown TM; Khodneva Y; Glasser SP; Richman JS; Howard G; Cushman M; Safford MM
    BMC Cardiovasc Disord; 2018 Apr; 18(1):66. PubMed ID: 29661151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers Associated with Atrial Fibrillation in Patients with Ischemic Stroke: A Pilot Study from the NOR-FIB Study.
    Tancin Lambert A; Kong XY; Ratajczak-Tretel B; Atar D; Russell D; Skjelland M; Bjerkeli V; Skagen K; Coq M; Schordan E; Firat H; Halvorsen B; Aamodt AH
    Cerebrovasc Dis Extra; 2020; 10(1):11-20. PubMed ID: 32028277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early NT-ProBNP (N-Terminal Probrain Natriuretic Peptide) Elevation Predicts Malignant Edema and Death After Reperfusion Therapy in Acute Ischemic Stroke Patients.
    Zhang X; Yan S; Zhong W; Yu Y; Lou M
    Stroke; 2021 Jan; 52(2):537-542. PubMed ID: 33406870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarker-based risk prediction in the community.
    AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
    Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of blood biomarkers to predict poor outcome after acute transient ischemic attack or ischemic stroke.
    Whiteley W; Wardlaw J; Dennis M; Lowe G; Rumley A; Sattar N; Welsh P; Green A; Andrews M; Sandercock P
    Stroke; 2012 Jan; 43(1):86-91. PubMed ID: 22020034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of myocardial infarction by N-terminal-pro-B-type natriuretic peptide, C-reactive protein, and renin in subjects with cerebrovascular disease.
    Campbell DJ; Woodward M; Chalmers JP; Colman SA; Jenkins AJ; Kemp BE; Neal BC; Patel A; MacMahon SW
    Circulation; 2005 Jul; 112(1):110-6. PubMed ID: 15983245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course and prognostic value of plasma levels of N-terminal pro-brain natriuretic peptide in patients after ischemic stroke.
    Yip HK; Sun CK; Chang LT; Chen MC; Liou CW
    Circ J; 2006 Apr; 70(4):447-52. PubMed ID: 16565563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma N-terminal pro-B-type natriuretic peptide as a predictor of perioperative and long-term outcome after vascular surgery.
    Schouten O; Hoeks SE; Goei D; Bax JJ; Verhagen HJ; Poldermans D
    J Vasc Surg; 2009 Feb; 49(2):435-41; discussion 441-2. PubMed ID: 19028043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Classification of etiologic subtypes for transient ischemic attacks: clinical significance of lacunar transient ischemic attack].
    Ohara T; Yamamoto Y; Nagakane Y; Tanaka E; Morii F; Koizumi T
    Rinsho Shinkeigaku; 2011 Jun; 51(6):406-11. PubMed ID: 21735732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.